Redburn Atlantic upgraded shares of Lonza Group (OTCMKTS:LZAGY – Free Report) to a strong-buy rating in a research report sent to investors on Wednesday,Zacks.com reports.
Separately, The Goldman Sachs Group upgraded shares of Lonza Group to a “strong-buy” rating in a research report on Wednesday, October 9th.
Check Out Our Latest Report on LZAGY
Lonza Group Trading Up 2.4 %
About Lonza Group
Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments.
Further Reading
- Five stocks we like better than Lonza Group
- How to Most Effectively Use the MarketBeat Earnings Screener
- ServiceNow: Will the High-Flyer Finally Split in 2024?
- The Role Economic Reports Play in a Successful Investment Strategy
- MarketBeat Week in Review – 11/25 – 11/29
- What is an Earnings Surprise?
- These 3 Stocks Are Heavy Hitters in Alternative Asset Management
Receive News & Ratings for Lonza Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lonza Group and related companies with MarketBeat.com's FREE daily email newsletter.